{"name":"Triple-Gene, LLC","slug":"triple-gene-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxObW5BWHc4SzNGck5seXQ0ZDN0QU5fUmZVSkhyUnVmRUpQcmNFX3pMYkwzcnpHZVVBcVVJckxiV0dubEM0eDVvR0JudHJpX3JzN09tUFZ6SGUwT3BuaVB5LVlGMkhVNVRjelk5clpZV3EwYTVMTHRkY2JLX3FnZkZVMlZUVjVHaHp4S1ZFanpxbTFaTEgxb0xOci1vSFZMVWhkWW5neTlXVXNpRXdIQktCeDFGUDE5VkpPcDhTREt3WU1UcHRCWnBSTFNTQW9TS3FsRVZZV0trZks?oc=5","date":"2026-03-02","type":"regulatory","source":"Reuters","summary":"Intellia gets FDA nod to resume second gene therapy trial after safety pause - Reuters","headline":"Intellia gets FDA nod to resume second gene therapy trial after safety pause","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxOdUNreXBUMGt0Q05KYVJ3T09oeHZjQ1hWS2ZUU2g0S05yOTFCMjNmLTMwTGpJSDJOYkduWkFIZ1Q2ZjFUVFZnT2paeUtQUXNYa1N1TGdSYlZzYVAtV1VpeVFtRkVlZmZQd0JlX0NPcUxGODJMS0hXV2NUY2JrTTl1eXNyb2ZnOENGaUx0VUJfdVNOc3dhRzFPdnpvRl9DOUhkRF9uQmplRzVaOW8?oc=5","date":"2026-02-04","type":"deal","source":"Fierce Biotech","summary":"Lilly drops 3 pipeline drugs, including gene therapy from $1B Prevail buyout - Fierce Biotech","headline":"Lilly drops 3 pipeline drugs, including gene therapy from $1B Prevail buyout","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQT3JBZkpHV3ljREZFSzF2c1ZEMm9VR0JGcHh5S21DQnBONW1uM09DTlR6azhvcDJrRGVOb2ZkczBTT3FGYTQyZXJ4eVhKaWwwbHhZRHZaemFuU29aRWxqRU04MEM0RUhLZEtPRG1lSnd3VnB5Mm1kUjBMNVF4Y2FwWkxXaUxQdVdMRXFrb2lNc0lnUVM4Zk54ZmhISmNZdFl2aWs3SHJxSEJHT2s3dTdYRA?oc=5","date":"2025-10-31","type":"trial","source":"Fierce Biotech","summary":"4DMT eyes $420M deal from Otsuka, with cash aimed at retinal gene therapy's phase 3 plans - Fierce Biotech","headline":"4DMT eyes $420M deal from Otsuka, with cash aimed at retinal gene therapy's phase 3 plans","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNZE5zQ2tId1p6VUd4Y0V6X21qdEtCOWg4UHlpN2JrcFJZaUhyZ0pRLVRVZ3J3Sm4yY01fZEtVcjRza0ZFZnhaWjNRZFVYcGU3UkJ2WTdzUU8wcW4wTUY2OXdONnNGel9QZlFSWmF3SkNrWHpyallIZC1DM1cyYm5BanFyVS0zRV9uYTJEMTlfc2VCcTZRNTZtRUc0cERSM1diUlROVHYwSjk?oc=5","date":"2025-09-18","type":"deal","source":"Fierce Pharma","summary":"After buyout, bluebird bio hatches familiar new branding as Genetix Biotherapeutics - Fierce Pharma","headline":"After buyout, bluebird bio hatches familiar new branding as Genetix Biotherapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQLXRVRjFtRS1JN1VXV011a085Vjh3RTh3Xy12ZkFrWkc2VFVwTXNpNzZMNUpLaFBTOV9mUE8xamFtcGxBdHEwSlNxRmtUeXM1cEFhc2txYXR1akVIODFHalBPUGktVTJDRVhxcGdrTllObFMxaTFEaW14dHpyU1JMVzhiWmYtTDhlUXp2U1hsSVNJeDdsUHM1UVIzeUFYbk1SalJ4YlZpdkpSMVJpc2I0?oc=5","date":"2025-08-08","type":"regulatory","source":"Fierce Pharma","summary":"FDA restricts bluebird bio gene therapy Skysona after blood cancer reports - Fierce Pharma","headline":"FDA restricts bluebird bio gene therapy Skysona after blood cancer reports","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE1iUVl3S0pYZlpmZWRiSC1nYWZ0QzQ5TkdXX2Y1WkhrUVBBRU9oUEJIU0ZkMHhpTTJiYmxEMTFQNGxaRVE0NC10YjU1Y25tOE9YLVhHNlpCU2xEQlhRR2N3alQtbXNnbmptaVdZV2xlb0hGZzRET2hvUmRsOA?oc=5","date":"2025-02-18","type":"trial","source":"Fierce Biotech","summary":"2024's top 10 clinical trial flops - Fierce Biotech","headline":"2024's top 10 clinical trial flops","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxOSXUwU0Izalg0MDZfeWxveXlvSnJpZ0FQdmtXVGlOcFNNNnNxaC1Kcl94N2Fta1QzNXE0U05yd3I1dVZzZjU4bWxQalM4VkVVMDJZYU5NWjJJTUdPajlUY0VyU0VicndpOWZlUWgtNmJFcXdrYUFoSVpqaXNpVEdkekRVME9saXpkejljRlBBT085N0NycHZrVjQ3WHhSWEZ5NWloQ01rQ1MxT21CdkhjbktQc2JCX2M?oc=5","date":"2024-08-14","type":"pipeline","source":"Fierce Pharma","summary":"Bluebird stock plummets 18% with slow uptake of sickle cell disease gene therapy Lyfgenia - Fierce Pharma","headline":"Bluebird stock plummets 18% with slow uptake of sickle cell disease gene therapy Lyfgenia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxNbXRxQmpxRXZKTmpYNXRrUGZwalhnUy1maFRFZU5GOEg2VG1SSHpGd1c3U0dsSnhaZXI2RkZTZzF0TEI2SDRXdzdnY2xWRlNoLTR0bEVEUXctSDN2MnlBaHl4NHZSMmdzbzczWFpWdl9Tb0RYZlJpS1JIY0RVT3NnYmZ6cnF5VnR4bTlHZQ?oc=5","date":"2024-07-17","type":"pipeline","source":"InvestorPlace","summary":"3 Gene Editing Stocks That Could Grow Your Wealth - InvestorPlace","headline":"3 Gene Editing Stocks That Could Grow Your Wealth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxNYjExSnl0OEN5dXB0VEhRVkh0dEdZczlORTVXTHNveWNNMDY2TjVUNzhIMF9XcndfN2FySDFWczh5VEFsVFJMUUd4bnNFRld0eVNKTVFJSTl0MGRjSG5xem5mMDRDek1xbDhSUVlHZHRJVnBpV19zLVJkUzNVaVJoT3N1U2NLektiSVZFRXVySFk0N1JlS0RUS3o0Ylo2TVNxYjdmY3NlZDQwOFNLaVFlN25KeG5OTmVlUTFLYTdFUTFjWFAwN21r?oc=5","date":"2024-06-12","type":"trial","source":"Fierce Biotech","summary":"UPDATE: Pfizer's phase 3 gene therapy trial fails to improve function for boys with Duchenne muscular dystrophy - Fierce Biotech","headline":"UPDATE: Pfizer's phase 3 gene therapy trial fails to improve function for boys with Duchenne muscular dystrophy","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxQNkR2ZlIwRTIxS0pPTVRjM015WG5NZ2tjWjgwYlVHbFlPWGVKa1ltNEdCTERFVkNOd3lNSUxfak5ld3QyS2hpa2hUb1V1dHhkV19CSWdMVzNmV3hKLWxPS0lSajZmb0JCVHMwbVBOSExaMXd6QUVGc1BOcUg4UWFUNjlfSkR3T21FVmN1bHZhOGhBakQ4LW5CME95b0dUOUNGemNGdFo1UlFpbTV6MUdqdkd3cmJNMzYxUDNSWkREZXljZy1vS0F5SS1wVklfaHBXX3lNbWEtMUpXVDZL?oc=5","date":"2024-02-28","type":"pipeline","source":"Specialty Pharmacy Continuum","summary":"Cell and Gene Therapies: A Review of Current and Future Treatments - Specialty Pharmacy Continuum","headline":"Cell and Gene Therapies: A Review of Current and Future Treatments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQMnZnRUh1WnJUaVBVWk5GSk82emVUZUlaOUw0aTFCeTlHcmlSMHBvTDhJalA0ZTM4TUI5NkZhN01jY1RPOU1Ga0ZybDRPVWpsZVlUVEp0SkFUN2pnN3ViY1hlc2M5NnVhR1huR1JveFYxTGFZU2dmTTlhVEhQaVo2S0E3ZlNWMWtoY2lfTmJ5SVlBaVE2SG9FdHVxQ3FJQXJuekpDNUNlLUM?oc=5","date":"2024-01-17","type":"pipeline","source":"Fierce Pharma","summary":"Jaguar Gene Therapy investors carve out manufacturing unit as a separate company - Fierce Pharma","headline":"Jaguar Gene Therapy investors carve out manufacturing unit as a separate company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxNUTRGRFNmRjctNGI5OWFhbV9xUVc4TDFLanNBMk91Y1FmYmVfeDhQYVpiLTMyNE0tUzJDQ0NIZnV2VHpVUlZ5VVgxTVhwamxJY1p3Tno0alM4NkFDd3lnazVIMHFBTDhfZHdGZU1Kd3NSV1dWekk0cFIxbE8wY0xvWXpLcEo5Y1B6Q0E?oc=5","date":"2021-01-14","type":"pipeline","source":"drugdiscoverytrends.com","summary":"3 notable types of innovative drugs from 2020 - drugdiscoverytrends.com","headline":"3 notable types of innovative drugs from 2020","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}